Mujtaba Bala, Hakki Karagozoglu, Mohammed A S Abdullahi, Abubakar A Bello, Ramat O Braimah, Abdurrazaq O Taiwo, Seidu Bello
{"title":"坏疽性口炎复发:事实还是虚构?尼日利亚索科托Noma儿童医院34例患者临床分析","authors":"Mujtaba Bala, Hakki Karagozoglu, Mohammed A S Abdullahi, Abubakar A Bello, Ramat O Braimah, Abdurrazaq O Taiwo, Seidu Bello","doi":"10.1097/SCS.0000000000011569","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Noma is an infectious and potential lethal disease that destroys the orofacial structures in which the etiopathogenesis is not fully understood. Controversy exists about whether noma can recur. The aim of this retrospective study was to evaluate recurrence of noma in patients previously treated for acute phase of noma.</p><p><strong>Methods: </strong>The authors reviewed the medical records of 34 patients with symptoms of recurrent noma at the Noma Children Hospital, Sokoto, Nigeria. The study included 22 (64.7%) males and 12 (35.3%) females, aged between 3 and 15 years (mean±SD: 7.94±3.03 y).</p><p><strong>Results: </strong>All recurrences occurred at the same anatomic site as the initial presentation. The interval between initial treatment and recurrence ranged from 4 months to 5 years. The most common symptoms at recurrence were pain and ulceration in 12 (35.3%) patients. Necrotic bone was observed in 12 (35.3%) patients, while 22 (64.7%) patients had new fistulas through preexisting noma scars. Initial presentations showed 29 (85.3%) patients with hemoglobin (Hb) below 8 g/dL, compared with only 2 (5.9%) patients with hemoglobin (Hb) below 8 g/dL at recurrence. All patients responded well to antibiotics and wound debridement.</p><p><strong>Conclusion: </strong>This study highlights symptoms of recurrent noma at various intervals postinitial treatment. The findings suggest that while initial management is crucial, long-term follow-up is essential to monitor for recurrence and optimize patient outcomes.</p>","PeriodicalId":15462,"journal":{"name":"Journal of Craniofacial Surgery","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Recurrence of Noma: Fact or Fiction? A Clinical Review of 34 Patients From Noma Children Hospital, Sokoto, Nigeria.\",\"authors\":\"Mujtaba Bala, Hakki Karagozoglu, Mohammed A S Abdullahi, Abubakar A Bello, Ramat O Braimah, Abdurrazaq O Taiwo, Seidu Bello\",\"doi\":\"10.1097/SCS.0000000000011569\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Noma is an infectious and potential lethal disease that destroys the orofacial structures in which the etiopathogenesis is not fully understood. Controversy exists about whether noma can recur. The aim of this retrospective study was to evaluate recurrence of noma in patients previously treated for acute phase of noma.</p><p><strong>Methods: </strong>The authors reviewed the medical records of 34 patients with symptoms of recurrent noma at the Noma Children Hospital, Sokoto, Nigeria. The study included 22 (64.7%) males and 12 (35.3%) females, aged between 3 and 15 years (mean±SD: 7.94±3.03 y).</p><p><strong>Results: </strong>All recurrences occurred at the same anatomic site as the initial presentation. The interval between initial treatment and recurrence ranged from 4 months to 5 years. The most common symptoms at recurrence were pain and ulceration in 12 (35.3%) patients. Necrotic bone was observed in 12 (35.3%) patients, while 22 (64.7%) patients had new fistulas through preexisting noma scars. Initial presentations showed 29 (85.3%) patients with hemoglobin (Hb) below 8 g/dL, compared with only 2 (5.9%) patients with hemoglobin (Hb) below 8 g/dL at recurrence. All patients responded well to antibiotics and wound debridement.</p><p><strong>Conclusion: </strong>This study highlights symptoms of recurrent noma at various intervals postinitial treatment. The findings suggest that while initial management is crucial, long-term follow-up is essential to monitor for recurrence and optimize patient outcomes.</p>\",\"PeriodicalId\":15462,\"journal\":{\"name\":\"Journal of Craniofacial Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Craniofacial Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/SCS.0000000000011569\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Craniofacial Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/SCS.0000000000011569","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
Recurrence of Noma: Fact or Fiction? A Clinical Review of 34 Patients From Noma Children Hospital, Sokoto, Nigeria.
Objective: Noma is an infectious and potential lethal disease that destroys the orofacial structures in which the etiopathogenesis is not fully understood. Controversy exists about whether noma can recur. The aim of this retrospective study was to evaluate recurrence of noma in patients previously treated for acute phase of noma.
Methods: The authors reviewed the medical records of 34 patients with symptoms of recurrent noma at the Noma Children Hospital, Sokoto, Nigeria. The study included 22 (64.7%) males and 12 (35.3%) females, aged between 3 and 15 years (mean±SD: 7.94±3.03 y).
Results: All recurrences occurred at the same anatomic site as the initial presentation. The interval between initial treatment and recurrence ranged from 4 months to 5 years. The most common symptoms at recurrence were pain and ulceration in 12 (35.3%) patients. Necrotic bone was observed in 12 (35.3%) patients, while 22 (64.7%) patients had new fistulas through preexisting noma scars. Initial presentations showed 29 (85.3%) patients with hemoglobin (Hb) below 8 g/dL, compared with only 2 (5.9%) patients with hemoglobin (Hb) below 8 g/dL at recurrence. All patients responded well to antibiotics and wound debridement.
Conclusion: This study highlights symptoms of recurrent noma at various intervals postinitial treatment. The findings suggest that while initial management is crucial, long-term follow-up is essential to monitor for recurrence and optimize patient outcomes.
期刊介绍:
The Journal of Craniofacial Surgery serves as a forum of communication for all those involved in craniofacial surgery, maxillofacial surgery and pediatric plastic surgery. Coverage ranges from practical aspects of craniofacial surgery to the basic science that underlies surgical practice. The journal publishes original articles, scientific reviews, editorials and invited commentary, abstracts and selected articles from international journals, and occasional international bibliographies in craniofacial surgery.